American Society of Hematology

Figure 3

Outcome after allogeneic SCT according to the number of donor iNKTs in the graft. Dashed line is for iNKT >0.011 × 107/kg and continuous line for iNKT <0.011 × 107/kg. (A) Cumulative incidence of relapse. (B) Cumulative incidence of nonrelapse mortality. (C) Cumulative incidence of grade III to IV acute GVHD. (D) Cumulative incidence of NIH grade 2 to 3 chronic GVHD.

Outcome after allogeneic SCT according to the number of donor iNKTs in the graft. Dashed line is for iNKT >0.011 × 10⁷/kg and continuous line for iNKT <0.011 × 10⁷/kg. (A) Cumulative incidence of relapse. (B) Cumulative incidence of nonrelapse mortality. (C) Cumulative incidence of grade III to IV acute GVHD. (D) Cumulative incidence of NIH grade 2 to 3 chronic GVHD.

This Feature Is Available To Subscribers Only